Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Ark Therapeutics Group plc       GB0034251727

 SummaryChartsNewsCalendarCompanyFinancialsRevisions 
Financials ( GBP)
Sales 2013 -
EBIT 2013 -
Net income 2013 -
Debt 2013 -
Yield 2013 -
Sales 2014 -
EBIT 2014 -
Net income 2014 -
Debt 2014 -
Yield 2014 -
PER 2013 0,07
PER 2014 -
Capi. / Sales 2013 0
Capi. / Sales 2014 -
Capitalization 8,51 M
More Financials
Company
Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer.The company was founded by Peter Stephen Keen, John W. Martin, Seppo... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on ARK THERAPEUTICS GROUP PLC
03/02 ALLERGY THERAPEUTICS : Ups Profit, Revenue, Market Share In First Half
02/03 ARK THERAPEUTICS : Seals Deal To Buy Majority Stake In Premier Veterinary (CORRE..
01/28 ARK THERAPEUTICS : Seals Deal To Buy Majority Stake In Premier Veterinary
01/12 ALLERGY THERAPEUTICS : To Post 4% Rise In First-Half Revenue
2014 ARK THERAPEUTICS GROUP PLC : Reverse Split: 1 for 100
2014 ARK THERAPEUTICS : Posting of Circular
2014 ARK THERAPEUTICS : Says Proposed Reverse Takeover Plan Progressing Well
2014 ARK THERAPEUTICS : Half Yearly Report and Change of Registered Office
More news
Sector news : Generic Pharmaceuticals
03/29 JOHNSON & JOHNSON : BRIEF: Shiprock man pleads guilty to stealing wallet
03/29 GRIFOLS : to make a major equity investment in Alkahest
03/29 GLAXOSMITHKLINE : Britain to offer all infants meningitis B vaccine
More sector news : Generic Pharmaceuticals
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF